On Friday, Bionano Genomics Inc (NASDAQ: BNGO) opened lower -5.10% from the last session, before settling in for the closing price of $1.03. Price fluctuations for BNGO have ranged from $0.96 to $11.80 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 32.87% over the past five years. Company’s average yearly earnings per share was noted 72.17% at the time writing. With a float of $60.58 million, this company’s outstanding shares have now reached $61.23 million.
Let’s look at the performance matrix of the company that is accounted for 344 employees.
Bionano Genomics Inc (BNGO) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of Bionano Genomics Inc is 1.07%, while institutional ownership is 10.09%. The most recent insider transaction that took place on Jun 13 ’23, was worth 50,000. In this transaction Director of this company bought 65,789 shares at a rate of $0.76, taking the stock ownership to the 65,789 shares. Before that another transaction happened on May 16 ’23, when Company’s President and CEO bought 15,000 for $0.64, making the entire transaction worth $9,639. This insider now owns 806,474 shares in total.
Bionano Genomics Inc (BNGO) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 72.17% per share during the next fiscal year.
Bionano Genomics Inc (NASDAQ: BNGO) Trading Performance Indicators
Check out the current performance indicators for Bionano Genomics Inc (BNGO). In the past quarter, the stock posted a quick ratio of 1.17. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.66.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.64, a number that is poised to hit -0.65 in the next quarter and is forecasted to reach -1.27 in one year’s time.
Technical Analysis of Bionano Genomics Inc (BNGO)
Bionano Genomics Inc (NASDAQ: BNGO) saw its 5-day average volume 1.36 million, a negative change from its year-to-date volume of 1.66 million. As of the previous 9 days, the stock’s Stochastic %D was 28.28%. Additionally, its Average True Range was 0.08.
During the past 100 days, Bionano Genomics Inc’s (BNGO) raw stochastic average was set at 1.85%, which indicates a significant decrease from 11.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.49% in the past 14 days, which was lower than the 77.94% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1222, while its 200-day Moving Average is $2.4446. Nevertheless, the first resistance level for the watch stands at $1.0206 in the near term. At $1.0638, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.0975. If the price goes on to break the first support level at $0.9437, it is likely to go to the next support level at $0.9100. The third support level lies at $0.8668 if the price breaches the second support level.
Bionano Genomics Inc (NASDAQ: BNGO) Key Stats
There are currently 54,694K shares outstanding in the company with a market cap of 59.85 million. Presently, the company’s annual sales total 36,120 K according to its annual income of -232,490 K. Last quarter, the company’s sales amounted to 10,720 K and its income totaled -43,890 K.
